登录 | 注册    关注公众号  
微信公众号
搜索
 > 【NCAM-1】

NCAM-1信息

英文名称:Neural cell adhesion molecule 1
中文名称:神经细胞粘附分子-1
靶点别称:Neural cell adhesion molecule 1,CD56,NCAM1,NCAM,Neural Cell Adhesion Molecule, NCAM,CD56 Antigen,N-CAM-1,MSK39,NCAM-1,Antigen Recognized By Monoclonal Antibody 5.1H11
上市药物数量:0
临床药物数量:4
最高研发阶段:临床二期

NCAM-1产品列表

ACRO质量管理体系
 
评论(3)
NC1-H5223|Human NCAM-1 / CD56 Protein, His Tag (MALS verified)
  1. 159XXXXXXX6
  2. 0人赞
  3. 各个环节的、高质量的、 高批间稳定性的产品和服务,能满足药物研发及生产的严格标准,提高药物研发及生产的成功率。实施精益管理体系,不断提升服务质量。货期较短;从技术支持服务来看,对客户需求及时响应,提高发货速度、缩短到货周期;多层次行业交流平台,积极树立品牌形象。
  4. 2023-04-21
NC1-M52H4|Mouse NCAM-1 / CD56 Protein, His Tag
  1. 159XXXXXXX6
  2. 0人赞
  3. 应用流式抗体,效果正在使用中,一直有订购产品,品牌值得信赖,值得推荐给大家,分享给大家,希望能够有更多合作的机会
  4. 2022-10-27
NC1-M52H4|Mouse NCAM-1 / CD56 Protein, His Tag
  1. 151XXXXXXX5
  2. 0人赞
  3. NKP46靶点淘选后,我们分别进行了人原鼠原猴原的Pe Elisa,所以本次采购鼠原的蛋白是为了获得交叉反应后的优选克隆
  4. 2022-12-09
 

NCAM-1分子别名

CD56,MSK39,NCAM1,N-CAM-1

NCAM-1分子背景

NCAM1 belongs to the immunoglobulin superfamily of adhesion molecules. A wide range of alternatively spliced NCAM1 messenger RNAs (mRNAs) has been described to date, but only the 120-, 140-, and 180- kDa isoforms are commonly expressed. NCAM1 plays an important role in the regulation of neurogenesis, neurite outgrowth, proliferation, and cell migration, however, its function in hematopoiesis, including NK cells, is poorly understood. NCAM1 signaling is mediated either by homophilic or heterophilic interactions with fibroblast growth factor receptor (FGFR), L1-CAM, N-cadherin and other components of the extracellular matrix. Upon activation, NCAM1 triggers a variety of signaling cascades including FYN–focal adhesion kinase (FAK), MAPK, and phosphatidylinositol 3-kinase (PI3K) pathways.

NCAM-1临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验
Lorvotuzumab mertansine BB-10901; IMGN-901; huN-901-DM1; IMGN-901-TAP; huN-901-SPP-DM1 临床二期 Immunogen Inc 横纹肌肉瘤, 卵巢癌, 白血病, Merkel细胞癌, 小细胞肺癌, 肾母细胞瘤, 滑膜肉瘤, 多发性骨髓瘤, 神经母细胞瘤, 神经纤维肉瘤, 小细胞癌 详情
CUBT-906 CUBT-906 临床二期 Curative Biotechnology Inc 胶质母细胞瘤 详情
GD2/CD56 Bi-specific CAR-T Cell Therapy (Shenzhen Geno-Immune Medical Institute) bi-4SCAR GD2/CD56 临床二期 深圳市免疫基因治疗研究院 肿瘤 详情
IN-B015 IN-B-015; IN-B00004 临床一期 HK inno.N Corporation 肿瘤 详情

消息提示

请输入您的联系方式,再点击提交!

确定